Rising Competition And Compliance Will Test Margins But Spur Recovery

AnalystLowTarget

Not Invested

Consensus Narrative from 9 Analysts

Published

25 Apr 25

Updated

07 May 25

AnalystLowTarget's Fair Value

US$130.00

25.7% overvalued

18 Jun

US$163.44

-21.4%

-4.8%

-21.4%

-4.8%

You can edit this narrative until May 12 5:59 AM. Then, changes will post as Updates.

Author's Valuation

US$130.0

25.7% overvalued

AnalystLowTarget Fair Value

Narrative

Updates1

Shared on07 May 25

AnalystLowTarget made no meaningful changes to valuation assumptions.

AnalystLowTarget Fair Value

US$130

25.7% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.09%

Diversified Financial revenue growth rate

0.30%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

9.58%

Calculation

US$375.89m

Earnings '28

12.35x

PE Ratio '28

US$4.64b

Market Cap '28

US$4.64b

Market Cap '28

27.54m

No. shares '28

US$168.58

Share Price '28

US$168.58 Share Price '28

Discounted to 2025 @ 9.78% p.a.

US$127.43

Fair Value '25